FI760084A - - Google Patents

Info

Publication number
FI760084A
FI760084A FI760084A FI760084A FI760084A FI 760084 A FI760084 A FI 760084A FI 760084 A FI760084 A FI 760084A FI 760084 A FI760084 A FI 760084A FI 760084 A FI760084 A FI 760084A
Authority
FI
Finland
Application number
FI760084A
Other languages
Finnish (fi)
Other versions
FI61032B (fi
FI61032C (fi
Inventor
Frank Ratcliffe Atherton
Michael John Hall
Cedric Herbert Hassall
Robert Wilson Lambert
Peter Stuart Ringrose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3417/75A external-priority patent/GB1533239A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI760084A publication Critical patent/FI760084A/fi
Publication of FI61032B publication Critical patent/FI61032B/fi
Application granted granted Critical
Publication of FI61032C publication Critical patent/FI61032C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI760084A 1975-01-27 1976-01-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara peptidylfosfonsyror FI61032C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3417/75A GB1533239A (en) 1975-01-27 1975-01-27 Peptide derivatives of phosphonic and phosphinic acids
GB341775 1975-01-27
GB4778775 1975-11-20
GB4778775 1975-11-20

Publications (3)

Publication Number Publication Date
FI760084A true FI760084A (es) 1976-07-28
FI61032B FI61032B (fi) 1982-01-29
FI61032C FI61032C (fi) 1982-05-10

Family

ID=26238285

Family Applications (1)

Application Number Title Priority Date Filing Date
FI760084A FI61032C (fi) 1975-01-27 1976-01-15 Foerfarande foer framstaellning av terapeutiskt anvaendbara peptidylfosfonsyror

Country Status (26)

Country Link
US (1) US4016148A (es)
JP (1) JPS598278B2 (es)
AR (1) AR218850A1 (es)
AT (1) AT359217B (es)
AU (1) AU502919B2 (es)
BR (1) BR7600449A (es)
CA (1) CA1065857A (es)
CH (2) CH624965A5 (es)
DD (1) DD123756A5 (es)
DE (1) DE2602193C2 (es)
DK (1) DK143755C (es)
DO (1) DOP1976002544A (es)
ES (1) ES444622A1 (es)
FI (1) FI61032C (es)
FR (1) FR2298335A1 (es)
GR (1) GR58609B (es)
HU (1) HU176800B (es)
IE (1) IE42466B1 (es)
IL (1) IL48835A (es)
LU (1) LU74249A1 (es)
NL (1) NL177021C (es)
NO (1) NO146429C (es)
PH (1) PH16560A (es)
PL (1) PL99096B1 (es)
PT (1) PT64743B (es)
SE (2) SE424328B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351125A1 (fr) * 1976-05-14 1977-12-09 Hoffmann La Roche Derives peptidiques et procede pour leur preparation
GB1577232A (en) * 1976-05-14 1980-10-22 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids
IT1081511B (it) * 1976-07-13 1985-05-21 Hoffmann La Roche Derivati di peptidi e loro preparazione
GB1585076A (en) * 1976-07-13 1981-02-25 Roche Products Ltd Peptides of phosphonic and phosphinic acids
GB1585275A (en) * 1976-07-21 1981-02-25 Roche Products Ltd Peptide derivatives of phosphonic and phosphinic acids
US4179464A (en) * 1977-11-14 1979-12-18 Schultz Robert J Preparation of N-(phosphonoacetyl)-L-aspartic acid
EP0002039A1 (en) * 1977-11-19 1979-05-30 Ciba-Geigy Ag Phosphonous acid derivatives, processes for their preparation and their use in combating microorganisms
CA1108125A (en) * 1977-12-23 1981-09-01 Frank R. Atherton Olgiopeptide derivatives of phosphonic acid
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid
US4154759A (en) * 1978-08-10 1979-05-15 Henryk Dubicki Preparation of N-(phosphonoacetyl)-L-aspartic acid
US4331591A (en) * 1978-10-05 1982-05-25 Ciba-Geigy Corporation Chemical process for the production of α-aminophosphonic acids and peptide derivatives
DE2966111D1 (en) * 1978-10-05 1983-10-06 Ciba Geigy Ag Process for influencing plant growth
EP0026867A1 (de) * 1979-09-28 1981-04-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Peptidylphosphonsäuren, deren Herstellung und Verwendung und sie enthaltende pharmazeutische Präparate
JPS5831992A (ja) * 1981-08-19 1983-02-24 Kyowa Hakko Kogyo Co Ltd 新規生理活性物質k−4およびその製造法
JPS57156498A (en) * 1981-03-20 1982-09-27 Kyowa Hakko Kogyo Co Ltd Novel physiologically active substance k-26
JPS5885897A (ja) * 1981-11-17 1983-05-23 Kyowa Hakko Kogyo Co Ltd 光学活性な1−アミノ−2−(4−ヒドロキシフエニル)エチルホスホン酸およびその誘導体
EP0103867B1 (en) * 1982-09-17 1986-12-17 Kyowa Hakko Kogyo Co., Ltd. Phosphorus-containing peptide derivative
PT77368A (en) * 1982-09-27 1983-10-01 Lilly Co Eli Improved process for preparing immunomodulating agents or rela-ting there to
US4482488A (en) * 1982-09-27 1984-11-13 Eli Lilly And Company Antibiotic A53868 and process for production thereof
US4463092A (en) * 1982-09-27 1984-07-31 Eli Lilly And Company Process for production antibiotic A53868
DE3669512D1 (de) 1985-06-11 1990-04-19 Ciba Geigy Ag Mikrobizide mittel.
FR2584077B1 (fr) * 1985-06-28 1988-07-08 Irceba L-di ou tripeptides possedant une activite biologique utilisable en medecine humaine et veterinaire, procede pour leur obtention et medicament en contenant
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
HUT52785A (en) * 1988-03-03 1990-08-28 Squibb & Sons Inc Process for producing 1,2-hydroxy-phosphonates and derivatives
JPH03505875A (ja) * 1988-07-08 1991-12-19 スミスクライン・ベックマン・コーポレイション レトロウイルス・プロテアーゼ結合ペプチド
US5468732A (en) * 1989-02-16 1995-11-21 Pfizer Inc. Phosphorus containing renin inhibitors
WO1990009172A1 (en) * 1989-02-16 1990-08-23 Pfizer Inc. Phosphorus containing renin inhibitors
US5321153A (en) * 1992-06-15 1994-06-14 Monsanto Company Process for making chiral alpha-amino phosphonates selected novel chiral alpha-amino phosphonates
US5473092A (en) * 1992-11-20 1995-12-05 Monsanto Company Synthesis of optically-active phosphono analogs of succinates
GB0022556D0 (en) * 2000-09-14 2000-11-01 Oxoid Ltd Improvements in or relating to selective agents for biological cultures
AU2001286121A1 (en) * 2000-09-18 2002-04-02 Newcastle Upon Tyne Hospitals Nhs Trust Selective growth media

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3893992A (en) * 1970-11-19 1975-07-08 Rohm & Haas N-acylated peptides of amino aromatic sulfonic acids and their derivatives
GB1445087A (en) * 1972-11-08 1976-08-04 Ici Ltd Preparing n-phosphonomethylglycine and nitrile intermediates therefor
US3954860A (en) * 1973-08-06 1976-05-04 Monsanto Company Phosphorous compounds
US3969398A (en) * 1974-05-01 1976-07-13 Monsanto Company Process for producing N-phosphonomethyl glycine

Also Published As

Publication number Publication date
DOP1976002544A (es) 1982-11-29
NO760231L (es) 1976-07-28
NL7600539A (nl) 1976-07-29
CH624965A5 (es) 1981-08-31
IL48835A0 (en) 1976-03-31
JPS598278B2 (ja) 1984-02-23
FR2298335A1 (fr) 1976-08-20
HU176800B (en) 1981-05-28
AR218850A1 (es) 1980-07-15
DE2602193C2 (de) 1982-07-08
NL177021C (nl) 1985-07-16
DK143755C (da) 1982-03-22
IL48835A (en) 1979-05-31
JPS5198223A (es) 1976-08-30
DK29576A (da) 1976-07-28
DK143755B (da) 1981-10-05
AU1035476A (en) 1977-07-21
GR58609B (en) 1977-11-10
BR7600449A (pt) 1976-08-31
AT359217B (de) 1980-10-27
CA1065857A (en) 1979-11-06
SE7710045L (sv) 1977-09-07
PH16560A (en) 1983-11-18
LU74249A1 (es) 1977-08-03
DE2602193A1 (de) 1976-07-29
CH623829A5 (es) 1981-06-30
US4016148A (en) 1977-04-05
IE42466B1 (en) 1980-08-13
PT64743B (en) 1978-01-04
IE42466L (en) 1976-07-27
ES444622A1 (es) 1977-10-16
SE7600731L (sv) 1976-07-28
PT64743A (en) 1976-02-01
SE424328B (sv) 1982-07-12
NL177021B (nl) 1985-02-18
FI61032B (fi) 1982-01-29
AU502919B2 (en) 1979-08-16
NO146429C (no) 1982-09-29
NO146429B (no) 1982-06-21
PL99096B1 (pl) 1978-06-30
FI61032C (fi) 1982-05-10
DD123756A5 (es) 1977-01-12
FR2298335B1 (es) 1980-06-20
ATA49276A (de) 1980-03-15

Similar Documents

Publication Publication Date Title
FR2298335B1 (es)
JPS5540873B2 (es)
JPS5256801U (es)
JPS5540112B2 (es)
JPS5268489U (es)
CH582460A5 (es)
BG22335A1 (es)
CH596591B5 (es)
CH595627A5 (es)
CH595613A5 (es)
CH594936A5 (es)
CH594743A5 (es)
CH594602A5 (es)
CH593320A5 (es)
CH592865A5 (es)
CH607460A5 (es)
CH589394A5 (es)
CH587505A5 (es)
CH586397A5 (es)
CH585086A5 (es)
CH606876A5 (es)
CH581556A5 (es)
BG22763A1 (es)
BG22748A1 (es)
BG22483A1 (es)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CO.